Selumetinib side effects vary in severity; if you encounter any issues, please consult your doctor promptly.Serious side effects of SelumetinibDuring ···【Read More】
Update: 2026-07-07Source: Haiou HealthViews: 216
Selumetinib Drug Interaction Dose AdjustmentCo-administration with Strong/Moderate CYP3A4 Inhibitors or FluconazolePrinciple: Avoid concomitant use wh···【Read More】
Update: 2026-07-07Source: Haiou HealthViews: 216
Selumetinib Dosage Adjustments for Adverse ReactionsIf intolerance persists after two dose reductions, permanently discontinue.Dose Reduction Scheme B···【Read More】
Update: 2026-07-06Source: Haiou HealthViews: 214
Selumetinib dosage and administration: What is the dosage of Selumetinib? The dosage is based on body surface area (BSA). The usual recommended dose i···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 197
For pregnant and lactating patients, if Sotorasib is to be used, it should be strictly in accordance with the doctor's advice, and do not use the ···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 232
Sotorasib Daily PrecautionsWhat daily precautions should be taken during Sotorasib treatment? It is important to actively maintain contact with your d···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 193
Mechanism of Action of SotorasibIrreversibly and selectively inhibits KRASG12C mutation, selectively inhibits KRAS signaling and cell growth in vitro,···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 201
Sotorasib is the first approved KRAS G12C-targeted therapy, indicated for the treatment of non-small cell lung cancer and colorectal cancer with KRAS ···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 185
Side Effects of SotorasibHematologicVery common (≥10%): lymphopenia (up to 48%), decreased hemoglobin (up to 43%), prolonged activated partial thrombo···【Read More】
Update: 2026-07-03Source: Haiou HealthViews: 207
Use of Sotorasib may cause a range of side effects, some of which are serious and require prompt medical attention. During treatment with Sotorasib, c···【Read More】
Update: 2026-07-02Source: Haiou HealthViews: 203
If adverse reactions occur, a maximum of 2 dose reductions are permitted: first dose reduction, 480 mg orally once daily; second dose reduction, 240 m···【Read More】
Update: 2026-07-01Source: Haiou HealthViews: 217
Sotorasib is indicated for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at leas···【Read More】
Update: 2026-06-30Source: Haiou HealthViews: 205
For HR-positive, HER2-negative breast cancer patients, the abemaciclib (BESIDX) from Lao Big Bear Pharmaceutical not only continues the clinical value···【Read More】
Update: 2026-06-25Source: Haiou HealthViews: 199
As an important alternative to the original drug, the abemaciclib generic (BESIDX) produced by Lao Big Bear Pharmaceutical has entered the market at a···【Read More】
Update: 2026-06-25Source: Haiou HealthViews: 187
Abemaciclib, marketed under the brand name BESIDX by Bigbear Pharma in Laos, is a CDK4/6 selective inhibitor indicated for hormone receptor (HR)-posit···【Read More】
Update: 2026-06-25Source: Haiou HealthViews: 206
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos